Why Aurinia Pharmaceuticals Stock Is Blasting Higher Today
Shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) jumped by 26% during today's regular trading session. In Friday's after-hours session, however, the biotech's shares jumped by another 10.3% on exceedingly heavy volume.
What's driving this sudden upward trend? A report from Bloomberg News today said that the biopharma heavyweight Bristol Myers Squibb (NYSE: BMY) might be interested in buying Aurinia Pharmaceuticals for an undisclosed sum. The report also noted that Bristol could still walk away from the negotiations.
Image source: Getty Images.
Source Fool.com